Regulus Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Rating) and Regulus Therapeutics (NASDAQ:RGLS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Volatility & Risk ASLAN Pharmaceuticals has a beta of […]

These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward.

Equities research analysts expect Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Rating) to post ($0.05) earnings per share for the current quarter, according to Zacks. Zero analysts have made estimates for Regulus Therapeutics’ earnings. Regulus Therapeutics posted earnings of ($0.08) per share in the same quarter last year, which indicates a positive year-over-year growth rate of […]